The IC(50) concept revisited.

Abstract:

:A major strategy used in drug design is the inhibition of enzyme activity. The ability to accurately measure the concentration of the inhibitor which is required to inhibit a given biological or biochemical function by half is extremely important in ranking compounds. Since the concept of the half maximal inhibitory concentration (IC(50)) is used extensively for studying reversible inhibition enzymatic reactions, it is important to clearly understand the experimental design and the mathematical modeling techniques used to generate IC(50) values. The most important part of the experimental design is to measure the rate of production of [P] during the linear phase of the time course of the reaction and to prove that the enzyme-catalyzed reaction is reversible. The most important part of the mathematical modeling is to select the correct model and to have a firm understanding on how to handle outliers in the data. These topics are discussed in greater detail along with a discussion on how much quantitative and mechanistic information can be reasonably deduced from an experiment.

journal_name

Curr Top Med Chem

authors

Caldwell GW,Yan Z,Lang W,Masucci JA

doi

10.2174/156802612800672844

subject

Has Abstract

pub_date

2012-01-01 00:00:00

pages

1282-90

issue

11

eissn

1568-0266

issn

1873-4294

pii

CTMC-EPub-20120507-007

journal_volume

12

pub_type

杂志文章,评审
  • L-Histidinol Dehydrogenase as a New Target for Old Diseases.

    abstract::Bacterial infections constitute an always growing health problem worldwide. The resistance to antibiotics of an increasing number of bacterial pathogens necessitates a permanent search for new molecules with different mechanisms of action. Histidine biosynthesis is an ancient pathway found in bacteria, archaebacteria,...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026616666160413140000

    authors: Monti SM,De Simone G,D'Ambrosio K

    更新日期:2016-01-01 00:00:00

  • Neuronal nicotinic acetylcholine receptor agonists: pharmacophores, evolutionary QSAR and 3D-QSAR models.

    abstract::Neuronal nicotinic acetylcholine ion channel receptors (nAChRs) exist as several subtypes and are involved in a variety of functions and disorders of the central nervous system (CNS), such as Alzheimer's and Parkinson's diseases. The lack of reliable information on the 3D structure of nAChRs prompted us to focus effor...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043451384

    authors: Nicolotti O,Altomare C,Pellegrini-Calace M,Carotti A

    更新日期:2004-01-01 00:00:00

  • Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutations in the Occurrence and Treatment of Pancreatic Cancer.

    abstract::Pancreatic cancer is a highly malignant tumor with a 5-year survival rate of less than 6%, and incidence increasing year by year globally. Pancreatic cancer has a poor prognosis and a high recurrence rate, almost the same as the death rate. However, the available effective prevention and treatment measures for pancrea...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026619666190828160804

    authors: Zhu Z,Xiao S,Hao H,Hou Q,Fu X

    更新日期:2019-01-01 00:00:00

  • QSAR in the pharmaceutical research setting: QSAR models for broad, large problems.

    abstract::The field of quantitative structure activity relationships (QSAR) has evolved into an integral tool for pharmaceutical discovery. It is presently an accessible technology, as can be shown by the number papers which are easily found through PubMed literature searches. At one level, QSAR is used routinely and invisibly ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610791111506

    authors: Sprous DG,Palmer RK,Swanson JT,Lawless M

    更新日期:2010-01-01 00:00:00

  • Predicting drug-likeness: why and how?

    abstract::There exists a huge attrition rate of molecules in clinical trials. It was expected that high-throughput screening and combinatorial chemistry would make the task of producing drugs easier. However, the efforts of the past decade have not been an unvarnished success. As a result, a lot of experimental and computationa...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026023392968

    authors: Ajay

    更新日期:2002-12-01 00:00:00

  • Rational understanding of nicotinic receptors drug binding.

    abstract::The atomic determination of the acetylcholine binding protein (AChBP), a molluscan cholinergic protein, homologous to the amino-terminal extracellular domain of nicotinic receptors (nAChRs), offers opportunities for the modeling of the acetylcholine binding site and its ligands. Recently, we constructed three-dimensio...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043451177

    authors: Grutter T,Le Novère N,Changeux JP

    更新日期:2004-01-01 00:00:00

  • Nucleoside analogs as anti-HBV agents.

    abstract::Chronic hepatitis B virus (HBV) infection affects about 400 million people worldwide. The development of nucleoside analogs that inhibit HBV polymerase provides an important approach for treating HBV infection. The approval of lamivudine, adefovir and entecavir represents a cornerstone of hepatitis B therapy. However,...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802606777303667

    authors: Zhou XX,Littler E

    更新日期:2006-01-01 00:00:00

  • MicroRNAs in peripheral artery disease.

    abstract::Peripheral arterial disease (PAD) is due to diffuse atherosclerosis. The pathological process is characterized mainly by the aberrant proliferation of vascular smooth muscle cells and the formation of neointimal lesions. MicroRNAs (miRNAs) are highly conserved non-coding small RNA molecules that regulate a large fract...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/15680266113139990107

    authors: Imanishi T,Akasaka T

    更新日期:2013-01-01 00:00:00

  • Coagulation factor Xa inhibition: biological background and rationale.

    abstract::Ischemic heart disease and cerebrovascular disease are the leading causes of death in the world. Surprisingly, these diseases are treated by relatively antiquated drugs. However, due to our improved understanding of the underlying pathology of these diseases, and a number of technological advances in tools for drug di...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026013395380

    authors: Leadley RJ Jr

    更新日期:2001-06-01 00:00:00

  • Biochemical and structural investigations on kynurenine aminotransferase II: an example of conformation-driven species-specific inhibition?

    abstract::Kynurenic acid (KYNA), one of the metabolites belonging to the kynurenine pathway, has been described as an important neuroprotective compound, its unbalancing being associated with several pathological conditions. In human brain, the majority of KYNA production is sustained by kynurenine aminotransferase II (KAT II)....

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/156802611794863599

    authors: Casazza V,Rossi F,Rizzi M

    更新日期:2011-01-01 00:00:00

  • Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies.

    abstract::The recognition that malfunction of the microtubule (MT) associated protein tau is likely to play a defining role in the onset and/or progression of a number of neurodegenerative diseases, including Alzheimer's disease, has resulted in the initiation of drug discovery programs that target this protein. Tau is an endog...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802611794072605

    authors: Ballatore C,Brunden KR,Trojanowski JQ,Lee VM,Smith AB 3rd,Huryn DM

    更新日期:2011-01-01 00:00:00

  • Advances in the development of macrocyclic inhibitors of hepatitis C virus NS3-4A protease.

    abstract::Hepatitis C virus (HCV) is a major cause of acute hepatitis and chronic liver disease, including cirrhosis and hepatocellular carcinoma (HCC). No vaccine is currently available to prevent hepatitis C, and the current standard of care (SOC) - pegylated interferon-α (PEG-IFN-α) in combination with ribavirin (RBV) - is o...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610792232051

    authors: Avolio S,Summa V

    更新日期:2010-01-01 00:00:00

  • Rexinoids for prevention and treatment of cancer: opportunities and challenges.

    abstract::Rexinoids are selective ligands for the nuclear receptors known as RXRs. They do not bind to the receptors for all-trans-retinoic acid (RARs). Many new rexinoids have been synthesized and then assayed for their ability to suppress proliferation of cancer cells, to inhibit activation of inflammatory cells of the tumor ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:

    authors: Liby KT,Sporn MB

    更新日期:2016-06-16 00:00:00

  • cycloSal-d4TMP pronucleotides structural variations, mechanistic insights and antiviral activity.

    abstract::Pronucleotides represent a promising alternative to improve the biological activity of nucleoside analogues against different viral diseases. The basic idea is to achieve nucleotide delivery into cells, bypassing limitations with intracellular formation of nucleotides from their nucleoside precursors. The cycloSal-con...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026023393183

    authors: Meiera C,Renzea J,Ducho C,Balzarini J

    更新日期:2002-10-01 00:00:00

  • On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue?

    abstract::Angiotensin II (AII), Asp1-Arg2-Val3-Tyr4-Ile5-His6-Pro7-Phe8, the primary active hormone of the Renin-Angiotensin-System (RAS), is a major vasoconstrictor implicated in the cause of hypertension. To unravel the question of the biologically active conformation(s) of this flexible peptide hormone and to better understa...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043451375

    authors: Tzakos AG,Gerothanassis IP,Troganis AN

    更新日期:2004-01-01 00:00:00

  • Strategies for the discovery and advancement of novel cationic antimicrobial peptides.

    abstract::Multi-drug resistant bacteria are appearing at an alarming rate and impose significant burdens on healthcare systems worldwide. Cationic peptides have shown great promise as broad spectrum antimicrobial agents with a demonstrated ability to kill resistant bacteria, however, issues such as protease susceptibility and t...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610793176648

    authors: Hadley EB,Hancock RE

    更新日期:2010-01-01 00:00:00

  • Copeptin as a biomarker in cardiac disease.

    abstract::The introduction of biochemical biomarkers in the evaluation of patients with cardiovascular disease has led to practice-changing advancements in the way these patients are diagnosed and managed. Measurements of cardiac troponins or brain-type natriuretic peptide (BNP) and its precursor, N-terminal brain-type natriure...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/15680266113139990088

    authors: Giannopoulos G,Deftereos S,Panagopoulou V,Kossyvakis C,Kaoukis A,Bouras G,Pyrgakis V,Cleman MW

    更新日期:2013-01-01 00:00:00

  • Inhibition of histone deacetylases: a pharmacological approach to the treatment of non-cancer disorders.

    abstract::The dynamics of gene expression are regulated by histone acetylases (HATs) and histone deacetylases (HDACs) that control the acetylation state of lysine side chains of the histone proteins of chromatin. The catalytic activity of these two enzymes remodels chromatin to control gene expression without altering gene sequ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802609788085241

    authors: Wiech NL,Fisher JF,Helquist P,Wiest O

    更新日期:2009-01-01 00:00:00

  • G Protein Coupled Receptors And Structure-Based Advances.

    abstract::G protein coupled receptors (GPCRs) are membrane proteins coupled with G proteins through which they transmit signals to the cytoplasm. Approximately 30% of pharmaceuticals target these receptors, even though crystal structures were scarce at the time. Furthermore, an additional 15% of GPCRs have yet to be exploited f...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026615666150915121324

    authors: Kontoyianni M

    更新日期:2016-01-01 00:00:00

  • The Importance of Bioactivation in Computer-Guided Drug Repositioning. Why the Parent Drug is Not Always Enough.

    abstract::Although bioactivation is a well-documented process and the role of active metabolites in the drug discovery field has long been recognized, drug metabolites are usually ignored in virtual screening campaigns oriented to drug repositioning. The present article discusses different issues related to overlooking of the a...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026616666160216155043

    authors: Talevi A

    更新日期:2016-01-01 00:00:00

  • Marcfortine and paraherquamide class of anthelmintics: discovery of PNU-141962.

    abstract::Three distinct chemical classes for the control of gastrointestinal nematodes are available: benzimidazoles, imidazothiazoles, and macrocyclic lactones. The relentless development of drug resistance has severely limited the usefulness of such drugs and the search for a new class of compounds preferably with a differ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026023393705

    authors: Lee BH,Clothier MF,Dutton FE,Nelson SJ,Johnson SS,Thompson DP,Geary TG,Whaley HD,Haber CL,Marshall VP,Kornis GI,McNally PL,Ciadella JI,Martin DG,Bowman JW,Baker CA,Coscarelli EM,Alexander-Bowman SJ,Davis JP,Zinser E

    更新日期:2002-07-01 00:00:00

  • New approaches for the treatment of pain: the GDNF family of neurotrophic growth factors.

    abstract::This article focuses on the GDNF family of neurotrophic factors as a potential new class of therapeutics for neuropathic pain, with a particular emphasis on the ligands, artemin and GDNF. In vivo activity of the ligands, expression of ligands and receptors after peripheral nerve injury, and modulation of nerve injury-...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026054367593

    authors: Sah DW,Ossipov MH,Rossomando A,Silvian L,Porreca F

    更新日期:2005-01-01 00:00:00

  • Therapeutic properties of mushrooms in managing adverse effects in the metabolic syndrome.

    abstract::Metabolic syndrome (MS) is a modern medical condition characterized by central obesity, hyperglycaemia, hypercholesterolemia and hypertension. The beneficial effects of mushrooms in lowering the symptoms of MS were known from both traditional and conventional medicine. Edible mushrooms, their extracts, polysaccharide ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/15680266113136660196

    authors: Kundaković T,Kolundžić M

    更新日期:2013-01-01 00:00:00

  • Nanoparticles vs cancer: a multifuncional tool.

    abstract::Nanotechnology is revolutionizing the development of different branches of science. The investigation of nanomaterials in the battle against cancer is not an exception. The main goal of this contribution is to bring an overview about the types of organic and inorganic nanomaterials that are under investigation for its...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026614666140118213316

    authors: Sanchez-Dominguez CN,Gallardo-Blanco HL,Rodriguez-Rodriguez AA,Vela-Gonzalez AV,Sanchez-Dominguez M

    更新日期:2014-03-01 00:00:00

  • Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

    abstract::With the global aging population, Alzheimer's disease, Parkinson's disease and mild cognition impairment are increasing in prevalence. The success of rapamycin as an agent to extend lifespan in various organisms, including mice, brings hope that chronic mTOR inhibition could also refrain age-related neurodegeneration....

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026615666150610125856

    authors: Jahrling JB,Laberge RM

    更新日期:2015-01-01 00:00:00

  • Terpyridines and their complexes with first row transition metal ions: cytotoxicity, nuclease activity and self-assembly of biomacromolecules.

    abstract::Transition metal complexes with terpyridine ligands have attracted a widespread interest with respect to biomedical applications: [(tpy)PtCl]Cl and [(tpy)RuCl(3)] are potent anti-tumor agents with activities comparable to those of cisplatin and carboplatin. The Ru(II) complexes feature a high potential as reactive pro...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802612799078919

    authors: Winter A,Gottschaldt M,Newkome GR,Schubert US

    更新日期:2012-01-01 00:00:00

  • New Drugs and Therapeutic/Diagnostic Targets for Fungal and Parasitic Diseases - Part I.

    abstract:: ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 社论

    doi:10.2174/156802661815181101110430

    authors: Dea-Ayuela MA,Serrano DR

    更新日期:2018-01-01 00:00:00

  • Biosynthesis of bacterial aromatic polyketides.

    abstract::Aromatic polyketides represent important members of the family of polyketides, which have displayed a wide assortment of bioactive properties, such as antibacterial, antitumor, and antiviral activities. Bacterial aromatic polyketides are mainly synthesized by type II polyketide synthases (PKSs). Whereas malonyl-CoA is...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802609789941906

    authors: Zhan J

    更新日期:2009-01-01 00:00:00

  • Stages of HIV replication and targets for therapeutic intervention.

    abstract::The replication cycle of human immunodeficiency virus (HIV) is divided into an early and a late phase. Most of the steps of the cycle have been targeted in antiviral therapy, although the drugs currently available for clinical use are only effective against two replication enzymes of the virus, either against the reve...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026033451781

    authors: Tözsér J

    更新日期:2003-01-01 00:00:00

  • (6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells.

    abstract::Estrogens control a wide number of aspects of human physiology and play a key role in multiple diseases, including cancer. Estrogens act by binding to and activating the cognate receptor (ER), however numerous studies have revealed that the G protein-coupled receptor named GPR30/GPER mediates also estrogen signals. As...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026615666150317221549

    authors: Sinicropi MS,Lappano R,Caruso A,Santolla MF,Pisano A,Rosano C,Capasso A,Panno A,Lancelot JC,Rault S,Saturnino C,Maggiolini M

    更新日期:2015-01-01 00:00:00